IXC
Click for more information
8.33% 6.5¢ invex therapeutics ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-24

  1. ralom
    17,489 Posts.
    lightbulb Created with Sketch. 416
    clock Created with Sketch.
    23/07/23
    23:30
    Post #: 68936305
    The reality is we have lost Prof Sinclair who was the driving researcher on exenatide .
    Just don’t really see how trials will continue
    IXC Price at posting: 18.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.5¢ 		Change
0.005(8.33%) 		Mkt cap ! $4.885M
Open High Low Value Volume
6.5¢ 6.5¢ 6.5¢ $1.02K 15.68K

Buyers (Bids)

No. Vol. Price($)
1 31311 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 7950 1
View Market Depth
Last trade - 10.07am 02/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.